Now, what big pharmaceutical is going to partner up and take Remplir into phase 3 trials in the US, we are so close yet so far, let’s hope towards the second half of the year or early next year
Such a waste, where Remplir could be doing good, with thousand of patients losing out because of the approval process / commercialisation process taking so long, let’s try and fast track this process and get Remplir to market
Now, what big pharmaceutical is going to partner up and take...
-
- There are more pages in this discussion • 431 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $64.05K | 168.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90080 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 47873 | 3 |
View Market Depth
| Last trade - 15.42pm 08/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |